Summit Partners Public Asset Management, LLC Glaukos Corp Call Options Transaction History

Summit Partners Public Asset Management, LLC

$2.79 Billion
Q3 2024

Call Options

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$113.62 - $135.39 $5.68 Million - $6.77 Million	50,000 New	50,000 $6.51 Million
Q4 2017 Feb 14, 2018	SELL	$24.5 - $36.01 $1.35 Million - $1.98 Million	-55,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$31.26 - $42.03 $1.72 Million - $2.31 Million	55,000	55,000 $1.82 Million

Others Institutions Holding GKOS

# of Institutions

341

Shares Held

46.8M

Call Options Held

132K

Put Options Held

188K

Black Rock Inc. New York, NY

8.04M
Shares

$1.16 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

5.87M
Shares

$844 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

2.18M
Shares

$314 Million
0.05% of portfolio
State Street Corp Boston, MA

1.95M
Shares

$281 Million
0.01% of portfolio
Ameriprise Financial Inc Minneapolis, MN

1.64M
Shares

$236 Million
0.06% of portfolio

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.84B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.

Account